First Lady Yumi Hogan is looking forward to the new headquarters of a pharmaceutical company coming to the Old Line State. Construction for the future home of UND-BIO’s U.S. R-and-D headquarters began yesterday. The South Korean pharmaceutical company will begin operations next year. It plans to focus on researching and developing insulin production.